Abstract

Nephritis is a common manifestation of systemic lupus erythematosus, a condition associated with inflammation and iron imbalance. Renal tubules are the work horse of the nephron. They contain a large number of mitochondria that require iron for oxidative phosphorylation, and a tight control of intracellular iron prevents excessive generation of reactive oxygen species. Iron supply to the kidney is dependent on systemic iron availability, which is regulated by the hepcidin-ferroportin axis. Most of the filtered plasma iron is reabsorbed in proximal tubules, a process that is controlled in part by iron regulatory proteins. This review summarizes tubulointerstitial injury in lupus nephritis and current understanding of how renal tubular cells regulate intracellular iron levels, highlighting the role of iron imbalance in the proximal tubules as a driver of tubulointerstitial injury in lupus nephritis. We propose a model based on the dynamic ability of iron to catalyze reactive oxygen species, which can lead to an accumulation of lipid hydroperoxides in proximal tubular epithelial cells. These iron-catalyzed oxidative species can also accentuate protein and autoantibody-induced inflammatory transcription factors leading to matrix, cytokine/chemokine production and immune cell infiltration. This could potentially explain the interplay between increased glomerular permeability and the ensuing tubular injury, tubulointerstitial inflammation and progression to renal failure in LN, and open new avenues of research to develop novel therapies targeting iron metabolism.

MeSH

Cells, Pathology, Ferroptosis, Lupus Nephritis, Nephritis, Glomerulonephritis

Cited by

• Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization. Oxid Med Cell Longev, 2022
• Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. Clin Immunol, 2023
• Immunometabolic alterations in lupus: where do they come from and where do we go from there? Curr Opin Immunol, 2022
• COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal, 2024
• Intricating connections: the role of ferroptosis in systemic lupus erythematosus. Front Immunol, 2025
• Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus. Expert Rev Clin Immunol, 2022
• Iron Inhibits the Translation and Activity of the Renal Epithelial Sodium Channel. Biology (Basel), 2022
• The Potential Role of Ferroptosis in Systemic Lupus Erythematosus. Front Immunol, 2022
• Intracellular iron accumulation throughout the progression of sepsis influences the phenotype and function of activated macrophages in renal tissue damage. Front Physiol, 2025
• Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus. Sci Immunol, 2023
• Comprehensive Analysis of Ferroptosis Markers in Lupus Nephritis Based on Bioinformatics Analysis and Experimental Validation. J Inflamm Res, 2025
• Animal models of lupus nephritis: the past, present and a future outlook. Autoimmunity, 2024
• Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest, 2022
• Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus. Front Immunol, 2022
• Iron metabolism in rheumatic diseases. J Transl Autoimmun, 2025